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Abstract To consider the relationships between, therapist
variability, therapy modality, therapeutic dose and therapy
ending type and assess their effects on the variability of
patient outcomes. Multilevel modeling was used to analyse
a large sample of routinely collected data. Model residuals
identified more and less effective therapists, controlling for
case-mix. After controlling for case mix, 5.8 % of the
variance in outcome was due to therapists. More sessions
generally improved outcomes, by about half a point on the
PHQ-9 for each additional session, while non-completion
of therapy reduced the amount of pre-post change by six
points. Therapy modality had little effect on outcome.
Patient and service outcomes may be improved by greater
focus on the variability between therapists and in keeping
patients in therapy to completion.
Keywords Therapist effect  Variability  Depression 
Drop-out  Dose effect
Introduction
The past 50 years has seen a concerted effort by
researchers to develop more effective models of therapy.
The dominant research method for testing the efficacy of
such models has been the randomised controlled trial
(RCT) and results have been summarised by national pol-
icy bodies [e.g., Substance Abuse and Mental Health Ser-
vices Administration (SAMDSA), National Institute for
Health and Care Excellence (NICE)] to support the adop-
tion of efficacious, evidence-based treatments into routine
clinical practice. For example, the Australian Department
of Health requires Medicare-funded treatments to be evi-
dence-based (Department of Health 2012), and treatment
provision decisions made by the American Medicare and
Medicaid governmental programs are influenced by the
AHRQ (Agency for Healthcare Research and Quality
2002).
In the UK, NICE (2016a) policy guidelines are used by
the UK Department of Health to decide which treatments
are to be funded by the National Health Service. For
depression in adults, NICE guidelines recommend Cogni-
tive Behaviour Therapy (CBT) as the most effective ther-
apy model, although inter-personal therapy (IPT) and to a
lesser extent, counselling are also supported (NICE 2016b).
The guidelines note that although provision of the latter
gives patients more choice, there is greater uncertainty
about its effectiveness (NICE 2016b).
In contrast to research into therapy models, there has
been relatively little research into the variability between
the therapists providing the therapy, despite therapists
representing a large resource (as well as cost) in clinical
settings. The phenomenon of therapist variability is termed
the therapist effect. In RCTs designed to compare therapy
models, such variability is often constrained by therapist
selection, training, supervision and close monitoring of
protocol adherence. Also, to reliably estimate the size of
therapist effects a large sample of therapists and a very
large sample of patients are required (e.g., Maas and Hox
2004; Soldz 2006), which can be problematic for RCTs.
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However, underestimating or ignoring therapist effects
risks overstating the effect of the therapy model (Kim et al.
2006). In order to estimate therapist effects, researchers
have focused on large samples of routinely collected data
from clinical practice (Elkin et al. 2006; Lambert and
Okiishi 1997; Soldz 2006). The study of these large data-
sets, to consider patient outcomes in ‘real world’ settings,
has been termed practice-based evidence (see Barkham
et al. 2010; Castonguay et al. 2013).
Accumulating evidence from both trials and routine data
has shown that therapists have a significant effect on
patient outcome. Results indicate that therapists account
for around 5–10 % of unexplained variance in patient
outcomes, with 8–9 % being most commonly reported.
These results hold in different therapy models and after
controlling for confounding patient variables (Crits-Chris-
toph et al. 1991; Crits-Christoph and Mintz 1991; Kim
et al. 2006).
There has been little research into why some therapists
are more effective than others, even when delivering the
same therapy model and controlling for case-mix. Thera-
pist factors such as training, skill and experience (Beutler
et al. 2004) and adherence to treatment protocol (Webb
et al. 2010), have been found to be only weak predictors of
patient outcome. The strength of the therapeutic alliance
has been shown to be a stronger predictor (e.g. Arnow et al.
2013; Falkenstro¨m et al. 2013), with evidence indicating
that therapists vary in their ability to recognise and repair
ruptures to that alliance (Safran and Muran 2000).
In addition to studies of therapy models and therapist
effects, there is a growing body of evidence focusing on
variables involved in the implementation of psychological
therapy. Therapeutic ‘‘dose’’ (number of sessions received)
and non-completion (unilateral termination of therapy by
the patient, often termed ‘‘dropout’’) have seen particular
research interest.
Therapeutic dose has been found to be related to more
desirable clinical outcome and policy guidelines often
suggest optimum treatment lengths. For example, NICE
guidelines suggest 16–20 sessions of CBT for depression
(NICE 2016b). However, in practice most patients receive
fewer sessions, with 6 sessions of CBT being the average in
primary care in the UK (Health & Social Care Information
Centre 2014). Further, the precise relationship between
dose and outcome has been contentious (Baldwin et al.
2009; Barkham et al. 2006; Howard et al. 1986) and an
important question for policymakers and services is ‘‘how
much is enough’’?
Non-completion similarly remains an important issue
despite decades of research (Barrett et al. 2008). Large-
scale studies show that patients do not complete around
20–35 % of psychological therapy interventions (Cooper
and Conklin 2015; Hans and Hiller 2013; Roos and
Werbart 2013; Royal College of Psychiatrists 2013; Swift
and Greenberg 2012). Therapy non-completion greatly
impedes effective therapy delivery across treatment
modalities, contexts and patient populations (Barrett et al.
2008), and is associated with poorer clinical outcomes
(Cahill et al. 2003). Research has indicated that therapist
factors such as skill and experience, a weaker therapeutic
alliance and fewer attended sessions are associated with
increased therapy non-completion (Fernandez et al. 2015;
Roos and Werbart 2013).
Given the significance of therapist effects and the
importance of delivery factors such as therapeutic dose and
non-completion of therapy to patient outcomes, the current
study used a large sample of routinely collected data, to
consider how the variability between therapists outcomes
relates to the number of sessions patients attended and
whether they dropped out of therapy or not. As the sample
contained data from both CBT therapists and counsellors,
the variability in outcomes due to therapy model was also
considered.
Accordingly, the aim of the study was to use multilevel
modeling to estimate the size of therapist effect, controlling
for case-mix, then assess the variability in therapist effec-
tiveness in relation to: (1) treatment modality, CBT or
counseling; (2) therapeutic dose, the number of sessions
attended, and (3) treatment ending, completion or non-
completion.
Methods
Study Setting
The context for the present study is the UK government’s
Improving Access to Psychological Therapies (IAPT) ini-
tiative. IAPT aims to provide evidence-based psychologi-
cal interventions for common mental health problems in
primary care. In accordance with NICE guidelines (Na-
tional Institute for Health and Care Excellence 2011), IAPT
uses a stepped care therapy delivery model (CSIP Choice
and Access Team 2008), delivering high-intensity psy-
chological therapies, mainly cognitive behaviour therapy
(CBT) and counseling, at step 3.
Original Dataset
The initial data set comprised 39,520 patients who attended
the service from June 2010 to October 2013. The service
provides primary care psychological therapies at around 90
GP practices across a city with a population of around
550,000. In line with IAPT services nationally, the service
offers a stepped care model of care with the vast majority
of patients being offered a low intensity treatment at step 2,
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such as guided self-help, computerised CBT and educa-
tional groups. Patients with depression who are stepped–up
to step 3 are generally offered 8–12 sessions of one-to-one
therapy, either CBT or counseling, with the option to
extend to 20 sessions if necessary. The data collected by
the service conforms to the standardised IAPT minimum
dataset (IAPT MDS) and includes patient demographic
information, outcome measures and information about the
treatment in terms of therapy type, number of sessions
attended and type of treatment ending. Ethical approval for
the current study was granted by the regional ethics com-
mittee (16/YH/0028).
Study-Specific Data Set
Most patients (N = 25,619) received a step 2 treatment and
were excluded, as were patients who received other ther-
apies (e.g., couples and family therapy, behavioural acti-
vation). The service does not carry out formal diagnoses,
but patients were included in the current study if they
scored above the clinical cut-off on a standardized outcome
measure of depression (see later). Patients were included if
they received between two and 20 sessions of one-to-one
therapy (counselling or CBT), and completed a common
standardised outcome measure at the first and last session
of treatment. Further, to improve the reliability of param-
eter estimates only therapists with 20 or more patients were
included (Schiefele et al. in press).
The resulting dataset comprised 4034 patients [CBT:
1912 (47.4 %); Counseling: 2122 (52.6 %)] seen by 61
therapists (28 CBT, 33 counsellors). The mean (SD) age of
patients in the study sample was 42.1 (13.77) years, 70.1 %
were female, 90.0 % were white and 33.0 % were
unemployed.
Measurement: Assessment and Outcome
Our primarymeasurewas the Patient HealthQuestionnaire-9
(PHQ-9; Kroenke et al. 2001). The PHQ-9 is a nine item
measure of depression. Each item is rated from 0 to 3. Scores
can range from 0 to 27, with higher scores indicating more
symptoms of depression. The primary outcome was the pre-
post change on the PHQ-9. Therefore, positive values were
indicative of patient symptom improvement, whilst negative
values indicated that their symptoms had worsened.
In a primary care population, the PHQ-9 has demon-
strated good internal validity (Cronbach’s a = 0.89), test–
retest reliability (0.84 intraclass correlation), and sensitiv-
ity and specificity (each 0.88 using a clinical threshold of
10) (Kroenke et al. 2001). The PHQ-9’s validity is sup-
ported in general and primary care populations (Cameron
et al. 2008; Martin et al. 2006), and it correlates highly with
the Beck Depression Inventory and 12-item General Health
Questionnaire (Martin et al. 2006). Although measures
were completed sessionally, the service could only provide
the first and final (pre and post) recorded scores. This
meant that although a final measure was available for both
therapy completers and drop-outs, the actual trajectories of
change during the course of therapy could not be analysed.
Instead, we produced a simple measure of ‘average change
per session’, by dividing the amount of pre-post change by
the number of sessions attended.
To determine statistically reliable and clinically signif-
icant improvement (i.e. ‘recovery’) rates, we adopted the
procedures as set out by Jacobson and Truax (1991)—that
is, the change scores for patients had to be greater than the
reliable change index in order to take account of mea-
surement error, and the end point score had to move from
above the cut-off level to below this predetermined score.
For the PHQ-9, we used a cut-off score of 10 and a reliable
change index of 6 points (McMillan et al. 2010).
In order to compare therapist outcomes, significant case-
mix variables need to be controlled for in the analysis.
Variables available, in addition to intake PHQ-9 score,
were patient demographic variables, age, gender, ethnicity
and employment status and severity of anxiety at intake, as
measured by GAD-7 (Spitzer et al. 2006).
Analysis
The statistical concepts and methodology of MLM are fully
described elsewhere (e.g., Rasbash et al. 2009b; Rauden-
bush and Bryk 2002; Snijders and Bosker 2012). A single
level regression model containing explanatory patient
variables, with continuous variables grand mean centered
(Hofmann and Gavin 1998; Wampold and Brown 2005),
was developed. Explanatory variables were tested for sig-
nificance by dividing the derived coefficients by their
standard errors with values greater than 1.96 considered
significant at the 5 % level. The single level model was
extended to a multilevel model allowing the variance in
patient outcome to be split between the patient level (level
1) and the therapist level (level 2).
Multilevel modeling software MLwiN v2.30 (Rasbash
et al. 2009a) was used to estimate parameters, using Iter-
ative Generalised Least Squares (IGLS) procedures. Whe-
ther the multilevel model was a better fit for the data than
the single level model, and whether there was a significant
therapist effect, were tested by comparing the difference in
-2*loglikelihood ratios produced by the single and mul-
tilevel models, against the chi squared distribution for the
degrees of freedom of the additional parameters. Vari-
ability between therapists in the relationship between each
explanatory and outcome variable was considered using
random slope models.
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The size of the therapist effect is the proportion of the
total variance that is at the therapist level (level 2; Wampold
and Brown 2005). This therapist effect is the amount of
variability in patient outcomes that is attributable to unex-
plained differences between therapists, after controlling for
variables in the model (i.e., controlling for case-mix).
The therapist residuals produced by the model represent
the degree to which each therapist varies in their impact on
outcomes, relative to the average therapist. Positively
signed therapist residuals are associated with increasing
outcome scores (i.e. greater pre-post change), while nega-
tively signed residuals are associated with a reduction in
outcome score (i.e. less pre-post change). The size of the
residuals can therefore be used to make comparisons
between therapists (Goldstein and Spiegelhalter 1996;
Saxon and Barkham 2012).
The therapist residuals are assumed to have a normal
distribution and a mean of zero. By ranking and plotting
the residuals with their 95 % confidence intervals (CIs),
three groups of therapists were identifiable. Therapists
whose CIs crossed the average residual (zero), were not
considered significantly different to the average therapist.
Therapists whose CIs did not cross zero were considered
either significantly above or below average in their effect
on patient outcomes.
Following the development of the model containing
case-mix variables, our variables of interest, treatment
modality (as a therapist level variable), dosage and ending
type, were added to the model. Those found to be signifi-
cant predictors of outcome were then considered in relation
to the three groups of therapists, average, below average
and above average, identified above.
Results
Multilevel Model
The multilevel model was developed from a single level
regression model that included significant patient predic-
tors of pre-post change on the PHQ-9. A comparison of the
-2*loglikelihood ratios of the two models showed a sig-
nificant reduction when the effect of the therapist was
allowed to vary (v2(1) = 90.89, p\ 0.001), indicating that
the multilevel model was a better fit for the data and there
was a significant therapist effect. Consideration of the
quartile–quartile plots of the patient and therapist residuals
indicated that Normality can be assumed. (The multilevel
model is presented in ‘‘Appendix’’).
The negative coefficients in the model show that being
unemployed, non-white, or having greater intake severity
on GAD-7 reduced the amount of pre-post change on PHQ-
9. Higher intake scores on PHQ-9 were predictive of
greater improvement. However, this may be in part a sta-
tistical function in that higher PHQ-9 scores have more
scope to improve. There was also a significant interaction
between employment status and PHQ-9 intake score, with
unemployed patients who had higher PHQ-9 scores at
intake making less change than employed patients with
similar levels of severity.
Therapist Effect
The model indicates the intercept (average therapist pre-
post change) to be 7.847 with a variance (SE) of 2.117
(0.499). This is the therapist level variance. The variance
(SE) at the patient level is 34.641 (0.777), giving a total
variance of 36.758, of which 5.8 % is at the therapist level.
This therapist effect of 5.8 % represents the amount of
variability in patient outcomes attributable to therapists.
Therapist Residuals
Figure 1 illustrates the variability between therapists by
ranking and plotting the therapist residuals (u0j) produced
by the model with their 95 % confidence intervals. The
‘average’ therapist is represented by the dashed horizontal
line, where the residual equals zero, Therapists whose
confidence intervals do not cross zero are significantly
below average, highlighted on the left of the plot (N = 10),
or significantly above average, highlighted on the right of
the plot (N = 8). Most therapists (N = 43) were not sig-
nificantly different from the ‘average’ therapist.
Therapist Outcomes
Overall, the mean (SD) patient PHQ-9 score at intake was
17.2 (4.48), while the mean (SD) PHQ-9 score at the last
Fig. 1 Ranked therapist residuals produced by the model, with 95 %
confidence intervals (CIs)
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attended session was 10.4 (6.93) with a mean (SD) pre-post
change of 6.8 (6.33) points. The amount of patient change
ranged from -15 to 27 points, and 45.2 % of patients made
statistically reliable and clinically significant improvement.
Table 1 describes the clinical outcomes of the three
groups of therapists identified in Fig. 1 and shows above
average therapists to be over twice as effective as below
average therapists, with a mean (SD) pre-post change of
9.9 (1.65) points on the PHQ-9 and a mean (SD) recovery
rate of 63.7 % (9.69) compared with 4.2 (0.93) points and
25.6 % (6.43). The bulk of therapists had outcomes similar
to the overall patient outcomes above, with a mean pre-post
change (SD) of 6.8 (0.96) points and mean (SD) recovery
rate of 46.4 % (9.86). The non-overlapping ranges of
therapist outcomes for below and above average therapists
suggest that the model has identified two distinct groups in
terms of their outcomes.
Therapy Modality
Comparing raw patient outcomes between the two modali-
ties, CBT showed more pre-post change than counseling,
with a mean (SD) change of 7.3 (6.35) points compared with
6.3 (6.28) points, giving a small effect size (Cohen’s d) in
favour of CBT of 0.16. Therapy type was also significant
when added to the multilevel model, with counselling pro-
ducing 0.8 of a point less improvement than CBT after
controlling for other variables (coefficient:-0.84; SE: 0.41).
Patients receiving counseling were more likely to
complete therapy, with a non-completion rate of 29.4 %
compared with 33.4 % for CBT (v2(1) = 7.72, p = 0.005),
and tended to have fewer sessions. Patients receiving
counselling had a mean (SD) of 6.1 (3.56) (Median: 5)
sessions, compared with a mean (SD) of 8.1 (4.74) (Me-
dian: 8) sessions for CBT (M-W U Test: p\ 0.001).
When sessions attended and ‘therapy ending’ were
added to the model, and the effect of either was allowed to
vary between individual therapists (using random slopes),
modality was no longer significant. This suggests that the
variability between individual therapists is more important
than the variability between the therapy types in the
relationships between dose and outcome and ending and
outcome.
Therapeutic Dose
Overall, the mean (SD) number of sessions attended was
7.1 (4.29) with a median of 6 sessions (range 2–20) and a
mode of two sessions. Figure 2 shows the frequencies for
patients attending different numbers of sessions overall and
for patients who completed or did not complete therapy.
Figure 2 shows that for non-completers, the modal
number of sessions attended was two (31.5 %) and 86.9 %
had stopped attending prior to session 8. The modal num-
ber of sessions attended by therapy completers was eight
sessions (representing 10.7 % of all completers), with
47.1 % completing therapy prior to session eight and
36.3 % completing between sessions 8–12. The remaining
16.6 % completed therapy between sessions 13–20.
Patients who did not complete therapy attended, on aver-
age, half as many sessions as those who completed therapy
with a median (Range) of 4 (2–19) sessions, compared with
8 (2–20) sessions.
The average amount of pre-post change in PHQ-9
scores, across the number of sessions patients attended is
shown in the boxplot in Fig. 3. The median amount of
change ranged from 3 points at 2 sessions, to 10 points at
15 and 17 sessions, although there does not appear to be a
clear linear relationship between sessions and change. The
amount of change increases by around a point per session
up to 7 sessions, before levelling off at around 9 points of
change thereafter.
The number of sessions attended by patients was com-
pared between the three therapists groups identified in
Fig. 1. Above average therapists provided, on average, one
more session (Median: 7 sessions) than average therapists
(Median: 6 sessions) and below average therapists (Me-
dian: 6 sessions). This one session difference was signifi-
cant (K-W test: p\ 0.001). However, the significant
difference was only found for treatment completers (K-W
test: p\ 0.001), where above average therapists had a
median of 9 sessions compared with 8 sessions for average
Table 1 Outcomes for average
and above and below average
therapists identified by the
model
Therapist group
Below average Average Above average
N (%) therapists 10 (16.4) 43 (70.5) 8 (13.1)
N (%) patients 543 (13.5) 2958 (73.3) 533 (13.2)
Therapists pre-post change mean (SD) 4.2 (0.93) 6.8 (0.96) 9.9 (1.65)
Therapist pre-post change range 2.7–5.3 4.6–9.1 7.9–12.7
Mean (SD) recovery rate 25.6 (6.43) 46.4 (9.86) 63.7 (9.69)
Recovery rate range 16.0–37.1 21.9–71.4 49.6–75.8
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and below average therapists. There was no significant
difference between the three groups of therapists for
treatment dropouts, where the median number of sessions
for above and below average therapists was 4 sessions,
compared to 3 sessions for average therapists (K-W test:
p = 0.283).
The number of sessions attended (minus grand mean)
was a significant predictor of outcome when added to the
model, with a coefficient (SE) of ?0.410 (0.051), indicat-
ing that attending more sessions generally improved out-
comes, by about half a point on PHQ-9 for each additional
session. However, the relationship of sessions to outcome
was curvilinear and there was also a significant random
slope. The relationship between sessions attended and
outcome therefore varied across sessions and between
therapists. A positive covariance between sessions and
outcome (?0.238, SE: 0.079) shows that the variability
between therapists increases as the number of sessions
increases; that is, there is a ‘fanning-out’ of therapist
regression lines. The therapist effect found of 5.8 % is for
the mean number of sessions (7 sessions). However, this
effect varies between 2 % at two sessions to around 40 %
at 20 sessions, although estimates for higher numbers of
sessions are derived from small samples.
Figure 4 presents the recovery rates (statistically reliable
and clinically significant improvement) for patients seen by
the three groups of therapists identified in the caterpillar
plot (Fig. 1), across the number of sessions that patients
had attended by the end of therapy (i.e. their total dose at
discharge). Because of the small number of patients who
received more than 16 sessions (4.0 %, see Fig. 2),
recovery rates for patients attending more than 16 sessions
are not shown in Fig. 4. Only 15 (2.8 %) patients seen by
below average therapists had more than 16 sessions, of
whom 26.7 % recovered. For average therapists, 114
Fig. 2 Frequencies overall and for completers and non-completers
across the number of sessions attended
Fig. 3 Boxplot of patient pre-
post change on PHQ-9 across
the number of sessions attended
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(3.9 %) had more than 16 sessions of whom 52.6 %
recovered, while the number of patients attending more
than 16 sessions with above average therapists was 24
(4.5 %) with 75.0 % recovered.
The lines of best fit in Fig. 4 show the curvilinear
relationship between sessions attended and outcome as
indicated by the model. The R2 statistics for each of these
lines show they fit the data well, particularly for average
and above average therapists. The model also indicated that
there is less variability between therapists’ outcomes at
fewer sessions, and that the variability increases as the
sessions attended increases, the ‘fanning-out’ described by
the model. The above average therapists’ recovery rates
increase most rapidly as sessions increase from two to eight
sessions while the increase is more gradual for average and
particularly below average therapists. For patients who had
eight sessions, the above average therapists were over
twice as effective as below average therapists. After eight
sessions, recovery rates begin to level out for average and
above average therapists but decrease for the below aver-
age therapists. For patients who had twelve sessions, above
average therapists were three times as effective as below
average therapists.
Therapy Endings
The 1262 patients (31.3 %) who did not complete therapy
had significantly poorer outcomes compared to those who
completed therapy. Their mean (SD) final PHQ-9 score
was 15.5 (5.92) with a mean (SD) pre-post change of 2.9
(5.05) points. This compares with a final PHQ-9 score of
8.1 (6.10) and a pre-post change of 8.5 (6.07) points for
therapy completers. Only 12.2 % of non-completers made
statistically reliable and clinically significant improvement
while 3.4 % reliably deteriorated, which compares with
60.2 and 1.1 % for completers (all p values\0.001).
Adding ‘therapy ending type’ to the multilevel model
showed it to be a very strong predictor of outcome. Non-
completion reduced the amount of PHQ-9 improvement by
6 points on average (coefficient: -5.996; SE: 0.283)
compared to therapy completion. There was also a random
slope indicating the relationship between ending type and
outcome varied between therapists. The negative covari-
ance suggests less therapist variability for patients who did
not complete therapy. Modeling therapist effects for
dropouts and completers separately, found no significant
therapist effect for dropouts while the effect for completers
was 11.2 %. This difference is shown in Fig. 5, which uses
the model to plot predicted therapist mean pre-post change
for completers and non-completers, controlling for case-
mix and sessions. Therapists in the three different therapist
groups are colour coded, grey for average, green for above
average and red for below average. The plot shows the
greater variability between therapists for patients who
completed therapy than for patients who did not complete
therapy, with the different therapist lines ‘fanning-in’.
For patients who completed therapy, the above average
therapists’ outcomes are clearly distinct from those of
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below average therapists. The distinctions are less clear for
patients who did not complete therapy. Therapists’ out-
comes for non-completers correlated only weakly with
their outcomes for completers (Pearson’s r: 0.32,
p = 0.013). Table 2 describes the three therapist groups in
terms of their patient outcomes for completers and non-
completers.
The differences in non-completion rates between thera-
pist groups were significant, both between above average
therapists and average therapists (v2(1) = 5.77, p = 0.016),
and between above average and below average therapists
(v2(1) = 7.05, p = 0.008) (see Table 2).
Comparing outcomes for therapy completers showed the
differences in pre-post change between the three groups of
therapists to be significant (ANCOVA: F (2,2768) = 91.44,
p\ 0.001) and the differences between pairs of therapist
groups were also significant (all p values\ 0.001). Similar
results were obtained for recovery rates, (v2(2) = 137.03,
p\ 0.001).
However, for patients who did not complete therapy, the
only significant difference was between the recovery rates
for average and above average therapists (v2(1) = 4.37,
p = 0.037). There were no significant differences on all
other comparisons of outcomes with p values ranging from
0.08 to 0.994.
Discussion
In this study of the variability of patient outcomes in nat-
uralistic settings we sought to use practice-based evidence
to complement the evidence-based research that informs
policy, guidelines and service delivery. Using multilevel
modeling to identify more and less effective therapists
controlling for case-mix, we went on to consider therapist
variability and outcomes in relation to three delivery fac-
tors: treatment modality, dosage and therapy ending. Our
results indicate that differences between two evidence-
based therapy models were less important for patient out-
comes than the individual therapist they see, differences in
dosage and in particular, whether the patient completed
therapy or not. We also found that the effect that dose and
ending type had on patient outcomes varied between
therapists.
Therapist Effect
The overall therapist effect found, of 5.8 %, although
significant, is towards the lower end of the range of ther-
apist effects found elsewhere (Crits-Christoph and Mintz
1991; Wampold and Brown 2005). However, larger effects
were found where patients received more than the average
number of sessions or completed therapy. Therapists’
recovery rates ranged from 16 to 76 % but the majority of
therapists could not be considered significantly different
from the average therapist after controlling for case-mix.
However, the 13 % of therapists that were significantly
more effective than average had recovery rates that were
more than twice those of the 16 % of therapists identified
as significantly less effective than average.
Treatment Modality
We found an initial differential effect of therapy type, in
favour of CBT, however the effect was small and clinically
Table 2 Comparison of completer and non-completer outcomes for patients seen by the three therapist groups
Therapist group
Below average Average Above average
Completers Non completers Completers Non completers Completers Non completers
N (%) 359 (66.1) 184 (33.9) 2021 (68.3) 937 (31.7) 392 (73.5) 141 (26.5)
Pre-post improvement mean (SD) 5.6 (6.22) 2.3 (4.76) 8.5 (5.89) 3.0 (5.16) 11.3 (5.57) 3.2 (4.64)
Recovery rate (%) 36.5 10.3 61.0 13.3 78.1 7.1
Fig. 5 Predicted mean therapist pre-post change for patients who
completed and did not complete therapy
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insignificant. This supports NICE depression guidelines
(2016b) that, counseling should be available as an alter-
native to CBT and findings elsewhere that the therapy
modality may have little effect when bona fide treatments
of a specific condition are being compared (Luborsky and
Singer 1975; Owen et al. 2015; Wampold et al. 2000).
Moreover, we found that the small effect of therapy type
disappeared when the differences between individual
therapists in their relationships between dose and outcome
and ending type and outcome were modelled.
Therapeutic Dose
Our findings on the effect of dosage on outcomes develop
further the evidence presented elsewhere, that the effect of
dose varied between patients (Baldwin et al. 2009) and that
there was variability in the amount of change per session
achieved by different therapists (Okiishi et al. 2006). The
current study found that the effect of dosage on patient
outcomes varied between therapists, and that this vari-
ability increased as the dosage the patients received
increased. This may be in part due to ‘more sessions’ being
a reflection of the complexity and severity of a patient’s
condition, given the limited number of sessions routinely
offered, with additional sessions having to be agreed in
clinical supervision. That there is greater variability
between therapists for patients who are more difficult to
treat would support findings reported previously using a
different dataset (Saxon and Barkham 2012).
Generally, receiving more sessions improved outcomes,
on average, by just under half a point on PHQ-9 for each
additional session delivered. However, our results suggest
that the ‘quality’ or ‘strength’ of the dose varied between
therapists, with above average therapists yielding greater
benefit per session compared to other therapists. Why some
therapists can more rapidly improve their patient outcomes
compared to other therapists and also maintain high
recovery rates for patients receiving more sessions, needs
to be studied further as it has important implications for
effective and efficient therapy delivery.
Therapy Ending
Any benefits from additional sessions can only be realised if
patients do not drop out of therapy. Although the ending type
and sessions attended are linked, with a greater frequency of
non-completers at fewer sessions attended, our results show
that of the two, type of ending is more important. Patients
who complete a course of therapy improved, on average, by
6 more points as compared with patients who dropped out,
while the benefit of each additional session was half a point
on average. In terms of recovery rates, only 12 % of patients
who dropped out of therapy recovered compared with 60 %
for patients who completed therapy. This negative effect of
therapy dropout is consistent with other findings (e.g. Cahill
et al. 2003; Delgadillo et al. 2014).
There was less variability between therapist outcomes
for patients who dropped out of therapy, compared to
patients who completed. Our results indicate that although
all therapists’ outcomes were negatively affected by
dropout, there was a larger reduction in the recovery rate of
therapy dropouts, relative to the rate for completers, for
above average therapists compared to below average
therapists. This was due to the above average therapists
being considerably more effective with therapy completers.
That above average therapists had more therapy completers
also contributes to their relative effectiveness overall.
Research to date suggests therapist skills in building the
alliance and repairing ruptures seem to be strongly asso-
ciated with therapy completion or not (Roos and Werbart
2013; Safran and Muran 2000).
Limitations and Future Research
The naturalistic design of the study meant there was less
control over certain aspects of therapeutic provision. How-
ever, this design means that the study is representative of the
therapeutic provision routinely delivered in practice.
Although we used a sample of patients above clinical cut-off
on the PHQ-9 and focused on change in depression symp-
toms, controlling for anxiety, it was not known whether
depression was the focus of the therapy as this is not
recorded by the service and no formal diagnoses are made.
This is a limitation of the current study, although reports
indicate that depression and mixed anxiety and depression
are by far the biggest reasons for referral to IAPT services
(Health & Social Care Information Centre 2014).
The absence of other potential predictor and confounder
variables such as a measure of therapeutic alliance or
adherence was also a limitation. Treatment modality was the
only therapist variable available and future research should
investigate other therapist characteristics that may explain
some of the variability between therapists. It would also be
valuable for future research to examine sessional change
trajectories—in particular, comparing CBT and counseling
trajectories, and trajectories with more and less effective
therapists. This was not possible with the current dataset.
Finally, the current study was carried out at a single
IAPT site and results may not be generalizable to other
types of therapy service. Future research should investigate
therapist effects in relation to dose, treatment ending and
patient outcomes in very large datasets from multiple sites,
in order to consider any ‘site effects’. Where possible,
these datasets should include variables such as sessional
outcome measures, diagnosis and therapist factors and
characteristics.
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Summary and Conclusions
We found significant variability between therapists’ out-
comes after controlling for case-mix and that the effect on
outcomes of sessions attended and patient drop-out, varied
between therapists. More effective therapists were found to
have fewer therapy dropouts and be more effective with
therapy completers than less effective therapists. For
therapy completers, more effective therapists delivered one
more session on average than less effective therapists and
were able to achieve greater change per session.
The current findings suggest that the two factors often
given greater prominence in research, policy and delivery,
namely therapy type and dose, may be less important for
patient outcomes in services delivering evidence-based
therapies, than the variability between therapists and maxi-
mizing the likelihood of patients completing a course of
therapy. In order to inform therapist training, supervision and
recruitment, future research should consider the features and
characteristics of those therapists who are able to achieve
greater improvement in their patients and more able to keep
their patients in therapy to an agreed ending.
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Appendix
The multilevel model of pre-post change on PHQ-9,
including case-mix variables
PPchangeij ¼ b0j þ 0:503ð0:030ÞðFirstPHQ-gmÞij
þ0:098ð0:026ÞðFirstGAD-gmÞijþ
 2:577ð0:209ÞUnemployed 1ijþ
 1:392ð0:316ÞNonWhite 1ijþ
 0:216ð0:045ÞðFirstPHQ-gmÞ
 Unemployed 1ij þ eij
b0j ¼ 7:847ð0:226Þ þ u0j
u0jN 0; r2u0
 
r2u0 ¼ 2:117ð0:499Þ
eijN 0; r2e
 
r2e ¼ 34:641ð0:777Þ
2 loglikelihood¼ 25;841:764ð4034of 4034casesinuseÞ
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